Published in Eur J Pediatr on March 15, 2016
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 40.22
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell (1993) 6.25
Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros (2005) 2.46
CFTR biomarkers: time for promotion to surrogate end-point. Eur Respir J (2012) 2.11
Sharing individual patient data from clinical trials. N Engl J Med (2015) 2.09
Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet (2010) 1.22
Lung clearance index: evidence for use in clinical trials in cystic fibrosis. J Cyst Fibros (2013) 1.20
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. Lancet Respir Med (2013) 1.18
What's new in cystic fibrosis? From treating symptoms to correction of the basic defect. Eur J Pediatr (2008) 0.99
New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol Ther (2014) 0.95
Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J (2009) 0.92
Early referral to cystic fibrosis specialist centre impacts on respiratory outcome. J Cyst Fibros (2008) 0.90
Controlled clinical trials in cystic fibrosis--are we doing better? J Cyst Fibros (2005) 0.89
A new Clinical Trials Directive to boost academic trials? Lancet Respir Med (2013) 0.80
Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis. Eur Respir J (2013) 0.80
Organizing multicenter trials: lessons from the cooperative oncology groups. Prev Med (1991) 0.79